AI assistant
Sending…
Zymeworks Inc. — Director's Dealing 2023
Apr 11, 2023
32180_dirs_2023-04-10_0d94cc89-db84-4e5a-93a7-5e883803a655.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2023-04-10
Reporting Person: Miller Derek John Michael (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-04-10 | Stock Option (Right to Buy) | $9.37 | A | 50000 | Acquired | 2033-04-09 | Common Stock (50000) | Direct |
Footnotes
F1: Stock options vest in 36 equal monthly installments starting one month after grant date of April 10, 2023.